Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 301–301 | Cite as

Pembrolizumab/rituximab

Myocarditis, myositis-myasthenia gravis overlap syndrome and B-cell depletion: case report
Case report

Reference

  1. Esfahani K, et al. Alemtuzumab for immune-related myocarditis due to PD-1 therapy. New England Journal of Medicine 380: 2375-2376, No. 24, 13 Jun 2019. Available from: URL: http://doi.org/10.1056/NEJMc1903064 - Canada

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations